PD-L1, LAG-3, and GAL-3 Expression in Anal Squamous Cell Carcinoma

被引：0
|
作者：
Ju, Jennifer [1 ]
Mills, Anne [2 ]
Stelow, Edward [1 ]
机构：
[1] Univ Virginia Hlth Syst, Charlottesville, VA USA
[2] Univ Virginia, Charlottesville, VA USA
来源：
LABORATORY INVESTIGATION | 2019年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
660
引用
收藏
页数：2
相关论文
共 50 条
  • [31] PD-L1 and LAG3 Expression in Hepatocellular Carcinoma Associated with HCV and Steatohepatitis
    Xing, Dongmei
    Luan, Lan
    Zhu, Qingfeng
    Gani, Faiz
    Pawlik, Timothy
    Taube, Janis M.
    Anders, Robert A.
    LABORATORY INVESTIGATION, 2017, 97 : 426A - 426A
  • [32] PD-L1 and LAG3 Expression in Hepatocellular Carcinoma Associated with HCV and Steatohepatitis
    Xing, Dongmei
    Luan, Lan
    Zhu, Qingfeng
    Gani, Faiz
    Pawlik, Timothy
    Taube, Janis M.
    Anders, Robert A.
    MODERN PATHOLOGY, 2017, 30 : 426A - 426A
  • [33] A LAG-3/PD-L1 bispecific antibody inhibits tumour growth in two syngeneic colon carcinoma models
    Everett, Katy
    Kraman, Matthew
    Kmiecik, Katarzyna
    Allen, Natalie
    Faroudi, Mustapha
    Zimarino, Carlo
    Wydro, Mateusz
    Doody, Jacqueline
    CANCER IMMUNOLOGY RESEARCH, 2017, 5 (03)
  • [34] Expression of PD-L1 Antibody in Anal and Cervical Invasive Squamous Cell Carcinoma: Comparison of Two Clones
    Avadhani, Vaidehi
    Monsrud, Ashley
    Mosunjac, Marina
    Krishnamurti, Uma
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 501 - 502
  • [35] The expression of PD-1 and LAG-3 in periapical lesions
    Wang, Hai-Sheng
    Yang, Fu-Hua
    Li, Yuan
    Pei, Fei
    Kulkarni, Ashok B.
    Chen, Zhi
    Zhang, Lu
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2018, 10 (08): : 2677 - 2684
  • [36] Expression of PD-L1 Antibody in Anal and Cervical Invasive Squamous Cell Carcinoma: Comparison of Two Clones
    Avadhani, Vaidehi
    Monsrud, Ashley
    Mosunjac, Marina
    Krishnamurti, Uma
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 501 - 502
  • [37] A LAG-3/PD-L1 bispecific antibody inhibits tumor growth in two syngeneic colon carcinoma models
    Kraman, Matthew
    Kmiecik, Katarzyna
    Zimarino, Carlo
    Everett, Katy
    Faroudi, Mustapha
    Wydro, Mateusz
    Doody, Jacqueline
    CANCER RESEARCH, 2017, 77
  • [38] LAG-3/PD-L1 mAb2 can overcome PD-L1-mediated compensatory upregulation of LAG-3 induced by single-agent checkpoint blockade
    Faroudi, Mustapha
    Kraman, Matthew
    Fosh, Natalie
    Reader, Claire
    Gliddon, Daniel
    Seal, Claire
    Lucas, Christa
    Koers, Alexander
    Wydro, Mateusz
    Morrow, Michelle
    Brewis, Neil
    CANCER RESEARCH, 2019, 79 (13)
  • [39] PD-L1/LAG-3 bispecific antibody enhances tumor-specific immunity
    Jiang, Haiping
    Ni, Haiqing
    Zhang, Pan
    Guo, Xiaoli
    Wu, Min
    Shen, Haoran
    Wang, Jie
    Wu, Weiwei
    Wu, Zhihai
    Ding, Jiazheng
    Tang, Rong
    Zhou, Shuaixiang
    Chen, Bingliang
    Yu, Michael
    Jing, Hua
    Liu, Junjian
    ONCOIMMUNOLOGY, 2021, 10 (01):
  • [40] Generation and formatting of a bispecific Affimer biotherapeutic for the inhibition of the LAG-3 and PD-L1 pathway
    Basran, Amrik
    Jenkins, Emma
    Adam, Estelle
    Writer, Michele
    Laurent, Floriane
    Oumie, Assa
    Sivula, Jyrki
    Hillman, Jennifer
    Strong, Lisa
    West, Maureen
    Stanley, Emma
    CANCER RESEARCH, 2019, 79 (13)
12345